Women’s Cancer Research Foundation leadership, including John P. Micha, M.D., and Bram H. Goldstein, Ph.D., contributed to multiple peer-reviewed oncology publications in 2025. These published works span cancer prevention, immunotherapy in endometrial carcinoma, PARP inhibitors in ovarian cancer, and evidence-based public health research.

Cervical cancer is the fourth most frequent cancer and fourth leading cause of death in women. In 2020, 604,000 new cases and 342,000 deaths worldwide were estimated. A recent study endeavored to identify the association between BMI and cervical cancer and precancerous cervical lesions (PCL) in screened women.

New findings suggest that meeting recommended physical activity guidelines may be associated with lower odds of lower-extremity lymphedema in endometrial cancer survivors. Understanding this relationship is an important step in shaping evidence-based survivorship care.

Obesity is well established as a risk factor for endometrial cancer, also driving higher mortality rates among these patients. Previous research conducted at the University of Bergen had shown that relying solely on body mass index (BMI) to estimate obesity-related risk factors is insufficient. Instead, they found that a higher percentage of visceral fat is associated with poorer outcomes in endometrial cancer patients.

Rising rates of early-onset cancer have generated substantial and hence, clinical guidelines have shifted to recommend earlier screening for some cancers.

Emerging research shows that endometrial cancer diagnoses are increasing most rapidly in women under 50. This article explores key risk factors, including increased body mass index and diabetes, and explains why earlier education about endometrial cancer risk is essential.

Globally, 1 in 20 women will be diagnosed with breast cancer in their lifetime. Hence, early screening is crucial because the best prognosis is when breast cancer is diagnosed and treated in its earliest stages.

New research from a Roche study indicated that 31% of eligible millennials (a person born between the early 1980s and the late 1990s) have postponed or missed their cervical screening appointments. The findings were derived from a survey of 5,518 internet users aged 16-64.

A new systematic review published in the Annals of Internal Medicine takes a closer look at the current data and what it reveals is both promising and cautionary.

Discover impact of clinical trial participation on survival outcomes for gynecologic cancer patients, highlighting racial & ethnic insights.

A diet rich in a variety of nutritious foods might not only keep you healthier but also help in preventing cancer.

Emerging studies suggest that medical marijuana potentially fills a significant void in oncology.

The decision to undergo a risk-reducing mastectomy is a profound one for women facing a high risk of breast cancer.

As metabolic health continues to be a major concern, understanding and mitigating its role in cancer development is paramount.

Recent study draws attention to the role of physical activity during ovarian cancer treatment.

A recent study from Michigan State University found that people of color and white women are significantly underrepresented in RCTs.

Clinical trials are at the forefront of medical research, paving the way for groundbreaking treatments and advancements in cancer care.

Recent advancements in medical research have pointed towards the potential influence of diet on HPV infection rates.

The decision to remove ovaries during a hysterectomy for benign gynecologic conditions has been a topic of ongoing debate.

Breast cancer is one of the most common types of cancer affecting women worldwide. Early detection is key!